Daniel Bergé
Impact in
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 66
- Electroconvulsive Therapy Studies 2
-
- Cannabis and Cannabinoid Research 5
- Co-authors
- Antonio Bulbena (14 shared papers)Victor Pérez Sola (22 shared papers)Anna Mané (29 shared papers)Óscar Vilarroya (10 shared papers)P. Salgado (5 shared papers)Susanna Carmona (5 shared papers)Mariana Rovira (3 shared papers)Miquel Bernardo (21 shared papers)
- Journals
- Schizophrenia Research (9 papers)European Neuropsychopharmacology (8 papers)Psychiatry Research (6 papers)Revista de Psiquiatría y Salud Mental (5 papers)European Psychiatry (3 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Daniel Bergé
80 papers receiving 1.3k citations
Daniel Bergé's Hit Papers
Peers
Comparison fields: 5 of 65
- Psychiatry and Mental health 856
- Biological Psychiatry 39
- Pharmacology 95
- Clinical Psychology 136
- Cognitive Neuroscience 71
Countries citing papers authored by Daniel Bergé
This map shows the geographic impact of Daniel Bergé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bergé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bergé more than expected).
Fields of papers citing papers by Daniel Bergé
This network shows the impact of papers produced by Daniel Bergé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bergé. The network helps show where Daniel Bergé may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Bergé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 86 | |
| 2 | 2008 | 82 | |
| 3 | 2015 | 81 | |
| 4 | 2009 | 61 | |
| 5 | 2014 | 58 | |
| 6 | 2018 | 51 | |
| 7 | 2015 | 50 | |
| 8 | 2017 | 48 | |
| 9 | 2022 | 44 | |
| 10 | 2020 | 39 | |
| 11 | 2018 | 32 | |
| 12 | 2018 | 31 | |
| 13 | 2017 | 29 | |
| 14 | 2006 | 28 | |
| 15 | 2021 | 27 | |
| 16 | 2007 | 24 | |
| 17 | Reasons and subjective effects of cannabis use among people with psychotic disorders: a systematic review. | 2015 | 20 |
| 18 | 2017 | 20 | |
| 19 | 2018 | 20 | |
| 20 | 2015 | 19 |
About Daniel Bergé
Daniel Bergé is a scholar working on Psychiatry and Mental health, Pharmacology, Clinical Psychology, Public Health, Environmental and Occupational Health and Experimental and Cognitive Psychology, having authored 84 papers that have together received 1.3k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (66 papers), Cannabis and Cannabinoid Research (5 papers), Maternal Mental Health During Pregnancy and Postpartum (4 papers), Youth Substance Use and School Attendance (3 papers), Electroconvulsive Therapy Studies (2 papers), Functional Brain Connectivity Studies (2 papers), Birth, Development, and Health (1 paper) and Smoking Behavior and Cessation (1 paper). The work is most often cited by research in Psychiatry and Mental health (856 citations), Biological Psychiatry (39 citations), Pharmacology (95 citations), Clinical Psychology (136 citations) and Cognitive Neuroscience (71 citations). Daniel Bergé has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Antonio Bulbena, Victor Pérez Sola, Anna Mané, Óscar Vilarroya, P. Salgado, Susanna Carmona, Mariana Rovira, Miquel Bernardo, Clemente García‐Rizo and Julio Bobes. Their work appears in journals such as Schizophrenia Research, European Neuropsychopharmacology, Psychiatry Research, Revista de Psiquiatría y Salud Mental and European Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.